(2E)-1-(2-chlorophenyl)-3-(5-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

(R)-2-(PYRROLIDIN-3-YL)PROPAN-2-OL HCL, 95%, 250mg

3-Methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine, 97%, 250mg

2'-Trifluoromethylphenyl acetylene, 98.0%, 25g

2,2,2-Trifluoro-1-(2-nitrophenyl)ethanone, 95.0%, 1g

Benzoyl bromide, 95.0%, 5g

4-Bromo-1-methoxy-2-Naphthalenecarboxaldehyde, 95%, 100mg

6-Methoxytryptamine>98.0%(HPLC)(T)100mg

GC capillary column ROTI®Cap-5 HT, 15 m, 0.25 mm, 0.10 µm, 1 Piece(s)

(2E)-3-phenyl-1-(thiophen-2-yl)prop-2-en-1-one, 95.0%, 250mg

Methyl 6-bromopyrazine-2-carboxylate, 95.0%, 5g

(S)-2-(2-Oxopyrrolidin-1-yl)butanamide, 95.0%, 1kg

(S)-(+)-2,2,2-Trifluoro-1-(9-anthryl)ethanol [e.e. Determination Reagent by NMR]>99.0%(GC)100mg